Key facts
- Notable investors include Infinity Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kyushu Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Kyushu Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kyushu Pharmaceutical
Manufacturer of advanced pharmaceutical products intended to support innovative drug research and manufacturing. The company offers expertise in small molecule and peptide API development, comprehensive CDMO capabilities, and global R&D facilities, enabling pharmaceutical enterprises worldwide to accelerate drug discovery and achieve reliable commercialization
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Kyushu Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kyushu Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kyushu Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.